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Mutations in ASPH Cause Facial Dysmorphism,
Lens Dislocation, Anterior-Segment Abnormalities,
and Spontaneous Filtering Blebs, or Traboulsi Syndrome
Nisha Patel,1,9 Arif O. Khan,1,2,9 Ahmad Mansour,3 Jawahir Y. Mohamed,1 Abdullah Al-Assiri,4
Randa Haddad,3 Xiaofei Jia,5 Yong Xiong,5 Andre´ Me´garbane´,6 Elias I. Traboulsi,7
and Fowzan S. Alkuraya1,8,*
We have previously described a syndrome characterized by facial dysmorphism, lens dislocation, anterior-segment abnormalities, and
spontaneous filtering blebs (FDLAB, or Traboulsi syndrome). In view of the consanguineous nature of the affected families and the likely
autosomal-recessive inheritance pattern of this syndrome, we undertook autozygosity mapping and whole-exome sequencing to
identify ASPH as the disease locus, in whichwe identified two homozygousmutations. ASPH encodes aspartyl/asparaginyl b-hydroxylase
(ASPH), which has been found to hydroxylate aspartic acid and asparagine residues on epidermal growth factor (EGF)-domain-
containing proteins. The truncating and missense mutations we identified are predicted to severely impair the enzymatic function of
ASPH, which suggests a possible link to other forms of ectopia lentis given that many of the genes implicated in this phenotype encode
proteins that harbor EGF domains. Developmental analysis of Asph revealed an expression pattern consistent with the proposed link to
the human syndrome. Indeed, Asph-knockout mice had a foreshortened snout, which corresponds to the facial abnormalities in
individuals with Traboulsi syndrome. These data support a genetic basis for a syndromic form of ectopia lentis and the role of aspartyl
hydroxylation in human development.The eye is a key sensory organ, and the remarkable conser-
vation of its developmental signals across distant species
has facilitated the unraveling of much of themolecular un-
derpinning of that developmental process.1 Remarkably,
more than 90% of human genes are expressed at some
stage in at least one ocular tissue, which argues for the
complex genetic network that controls the development
and function of the eye.2 Not surprisingly, ocular abnor-
malities are common features of numerous syndromes,
and in some instances, the defects can be highly distinctive
or pathognomonic. One of the less commonmalformation
syndromes with very distinctive ocular features was first re-
ported in 1995 in a multiplex consanguineous family from
the Druze sect in Lebanon.3 Virtually all affected individ-
uals had dislocated crystalline lenses and anterior-segment
abnormalities, in addition to a highly characteristic face
with flat cheeks and a beaked nose. Several affected mem-
bers developed highly unusual nontraumatic conjunctival
cysts (filtering blebs) that were presumably caused by
abnormal thinning of the sclera. Two other Lebanese
families were subsequently reported, and an entry for
this syndrome was created in Online Mendelian Inheri-
tance In Man (MIM 601552).4,5 In the present report, we
describe an additional ethnically distinct Saudi Arabian in-
dividual with the same syndrome (Figure 1), which we pro-
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The Amdysmorphism, lens dislocation, anterior-segment abnor-
malities, and spontaneous filtering blebs) syndrome. We
were able to combine molecular genetic data from this
Saudi affected individual and data from two previously
published Lebanese affected individuals from distinct
families to determine that mutations in the gene encoding
an enzyme that hydroxylates aspartic acid and asparagine
residues of epidermal growth factor (EGF)-domain-con-
taining proteins are the likely cause of the syndrome.
Individual 1 (VII:1 in Figure 1) is a 19-year-old Saudi
female who first noticed visual difficulties at the age of
10 years. She is the first child of consanguineous parents,
and her younger siblings are unaffected by history
(Figure 1). She has no health issues except for her ocular
problems. Referral was for evaluation following the
implantation of scleral-fixated intraocular lenses in both
eyes within the preceding year to treat aphakia after the
removal of an anteriorly dislocated lens in the right eye
and spherophakia in the left eye. Her facial features were
consistent with FDLAB syndrome (Figure 1). Best-corrected
visual acuity was 20/25 in both eyes. Slit-lamp examina-
tion revealed stable intraocular implants and filtering blebs
and patchy iris atrophy in both eyes (Figure 1). Retinal
examination was within normal limits.
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Figure 1. Identification of Individuals with Traboulsi Syndrome and Mapping of Its Associated Locus
(A and B) Pedigree (A) and clinical images (B) of individual 1 from Saudi Arabia. Note the distinct facial features, including a beaked nose,
flat cheeks, retrognathia, filtering blebs (black triangles), and patchy iris atrophy. Scleral-fixated intraocular lenses are in place.
(C) Shared autozygous ASPH region between the three individuals on chromosome 8. Red denotes differences in calls of homozygous
SNPs, revealing the shared haplotype between individuals 2 and 3.
(D) Linkage analysis utilizing the three affected individuals revealed a single significant chromosome 8 peak (LOD> 4) corresponding to
the ASPH locus.inherited as part of an autozygous block. Therefore, we
enrolled the family in an institutional-review-board-
approved protocol with informed consent and proceeded
with autozygosity mapping followed by whole-exome
sequencing as described before.6–8 Iterative filtering (based
on homozygosity, novelty, predicted pathogenicity, and
location within the autozygome) of the resulting 70,436
variants yielded single variants in ASPH (MIM 600582;
encoding aspartyl/asparaginyl b-hydroxylase [ASPH]) and
CRISPLD1 (Figure S1, available online). We ruled out the
variant in CRISPLD1 (c.614A>G [p .Asn205Ser] [RefSeq
accession number NM_031461.5]) because it did not
map to the critical locus revealed by the additional
affected individuals (see below; Figure 1). The variant in
ASPH, a 5 bp indel (c.1852_1856delinsGGG [RefSeq
NM_004318.3]), is predicted to cause a frameshift with pre-
mature truncation (p.Asn618Glyfs*20). However, RT-PCR
on blood-derived RNA revealed that this indel results in
the complete skipping of exon 22 (r.1765_1900del),
in which it resides, and thus causes a frameshift
(p.Ser589Glufs*18) that is different from the predicted756 The American Journal of Human Genetics 94, 755–759, May 1, 2one, most likely because it removes an exon-splicing
element. The predicted result of this frameshift is complete
loss of the catalytic carboxyl terminal (Figure 2 and
Figure S2). This mutation is absent in 425 in-house Saudi
exomes, 100 Saudi controls by Sanger sequencing, and all
publically available variant databases. The unaffected
siblings were found to be either wild-type or heterozygous
for the mutation, whereas the unaffected parents were
both heterozygous.
In order to corroborate the human genetics link between
ASPH and Traboulsi syndrome, we sought additional
affected individuals. In this study, we included individual
2, who was the sole individual described by Mansour
et al.,5 and individual 3, corresponding to case II-7 in the
pedigree published by Haddad et al.4 Individual 2 is a
Lebanese single female who has lived all her life in an
orphanage, so her ancestry is unknown,whereas individual
3 is from a known Druze sect family. Genotyping of these
two individuals (2 and 3) revealed a single homozygous
interval shared by all three individuals in this study; it cor-
responds to the ASPH locus, which was further confirmed014
Figure 2. Identification of ASPH Mutations that Cause Traboulsi Syndrome
(A) DNA sequence chromatogram of the indel observed in individual 1.
(B) The upper panel shows a DNA sequence chromatogram with the homozygous missense mutation found in individuals 2 and 3. The
lower panel reveals strong conversation of the Arg735 residue, which is altered in these two individuals.
(C andD) Schematic showing thatmutations found in all three individuals only affect ASPH and not the other two isoforms, Junctin and
Junctate.
(E) The crystal structure of human ASPH (residues 562–758) shows the overall structure with the zinc ion and the cofactor analog
N-oxalylglycine bound at the active site.
(F) A zoomed-in view of the active site shows that the Arg735 side chain forms a pair of salt bridges with a carboxylate group of
N-oxalylglycine.
(G) A model of the p.Arg735Trp variant in ASPH shows that cofactor binding would be disrupted as a result of the loss of the critical salt
bridges and potential clashes with the bulky hydrophobic side chain of Trp.by linkage analysis (Figure 1). Consistent with the shared
haplotype between individuals 2 and 3, sequencing of
ASPH revealed a shared homozygous missense variant
(c.2203C>T [RefSeq NM_004318.3]) that affects an
absolutely conserved amino acid residue (p.Arg735Trp)
(Figure 2). The frequency of this allele in the NHLBI Exome
Sequencing Project Exome Variant Server is sufficiently low
(1 in 13,005) to be compatible with being disease causing,
even for a disease as rare as FDLAB. Furthermore, we note
that this allele is absent in 208 ethnically matched
(Lebanese Druze) control chromosomes.
To further support the candidacy of p.Arg735Trp as a
pathogenic variant, we set out to study its predicted effect
on the protein structure. The crystal structure of the cata-
lytic domain of human ASPH (residues 562–758) hasThe Ambeen determined by the Structural Genomic Consortium
at University of Oxford (Protein Data Bank ID
3RCQ; NCBI Gene ID 444) (Figure 2). The structure of
ASPH exhibits a typical fold that is conserved in all of
the Fe2þ-a-ketoglutarate-dependent dioxygenases. Eight b
strands form a barrel to accommodate the catalytically
essential cofactor and metal binding, and additional a
helices are present at the amino terminus (Figure 2). The
structure includes active-site-bound N-oxalylglycine and
zinc ion, which mimic the physiological cofactor 2-
oxoglutarate (also named a-ketoglutarate) and the catalytic
metal ion Fe2þ, respectively. It has been established that
the binding of the 2-oxoglutarate cofactor enables sub-
strate (side chain of aspartic acid or asparagine) recruit-
ment to the catalytic site and participates in a criticalerican Journal of Human Genetics 94, 755–759, May 1, 2014 757
Figure 3. Expression of Asph in the Developing Mouse Embryos
(A–F) Immunofluorescent staining of ASPH in E10.5 (A), E11.5 (C), and 12.5 (E) frozen eye sections. Note the strong localization in the
developing lens at all three stages. Negative controls are shown in (B), (D), and (F). The scale bar in (A) represents 50 mm.
(G–H)Whole-mount in situ hybridization of Asph revealed stronger expression in the limbs, snout, and eye (black triangles) of E11.5 (G)
and E12.5 (I) mouse embryos than in those of sense controls (H and J).step in the catalytic reaction (reviewed in Hewitson et al.9
and Schofield and Ratcliffe10). As revealed in the crystal
structure, Arg735 is a critical residue in that it forms a
pair of salt-bridge interactions with the cofactor and thus
orients it for proper coordination with the catalytic metal
ion (Figure 2). The p.Arg735Trp variant would abolish
the critical salt bridges and therefore disable the cofactor
binding, leading to a loss of ASPH activity (Figure 2). Alter-
ation of a charged Arg to a bulky hydrophobic Trp at posi-
tion 735 would also potentially interfere with the folding
of the protein, further abolishing its cellular function.
Thus, this predicted pathogenic variant, together with
the variant identified in individual 1, highly suggests
that mutations in ASPH cause Traboulsi syndrome.
The hydroxylase encoded by ASPH is specific to the
aspartic acid and asparagine residues that fall within the
consensus motif (CX[DN]4X[FY]XCXC) in EGF-domain-
containing proteins.11 This unusual posttranslational
modification, which appears to be EGF specific,12 was of
unclear significance until Dinchuk and colleagues showed
that it has developmental consequences.13 In carefully
engineered knockout mice in which only Asph, and not
the other two isoforms (which code for the two distinct
proteins Junctin and Junctate), was disrupted, they showed
that ASPH deficiency led to a complete loss of b-hydroxyl-
ation of the tested EGF-containing proteins. These mice
had a shortened snout that might correspond to the facial
malformations of individuals with Traboulsi syndrome.
Unfortunately, the eyes were not examined in these
mice, so it is not clear whether the mice recapitulated the
human eye phenotype. In order to shed more light on
the developmental role of Asph in the eye and craniofacial
region, we set out to examine the developmental profile of
Asph in developing mouse embryos by whole-mount
in situ hybridization. As shown in Figure 3, Asph was
strongly expressed in the snout, limbs, and eye of embry-
onic day 11.5 (E11.5) and E12.5 mouse embryos. Immu-758 The American Journal of Human Genetics 94, 755–759, May 1, 2nofluorescent staining of ASPH in E10.5–E12.5 mouse
eye sections showed strong localization of the protein in
the lens of the developing eye at all three stages (Figure 3).
This is highly consistent with a previously published data
set that highlights Asph as one of the genes in the top
two percentiles of genes enriched with lens expression.14
We note that the two mutations we identified in this
study are specific to the ASPH isoform and are not expected
to influence Junctin or Junctate isoforms, which strongly
suggests that the pathogenesis of Traboulsi syndrome is
restricted to aspartic acid and asparagine hydroxylation
activity, given that the latter activity distinguishes ASPH
from the other two proteins. Interestingly, virtually all of
the genes implicated in syndromic or isolated forms of
ectopia lentis (FBN1 [MIM 134797], ADAMTSL4 [MIM
610113], ADAMTS10 [MIM 608990], and ADAMTS17
[MIM 607511]) encode proteins that harbor EGF
domains.15,16 Thus, it is tempting to speculate that failure
of aspartic acid and asparagine hydroxlation of these pro-
teins is a mechanism by which ASPH deficiency results in
a lenticular phenotype overlapping that associated with
these genes, although other independent disease-causing
mechanisms remain possible.
In summary, we provide evidence that ASPH is mutated
in a distinct form of syndromic ectopia lentis. Our develop-
mental analysis of Asph is consistent with previously
published phenotypes in Asph-knockout mice. Resulting
from ASPH deficiency, loss of aspartic acid and asparagine
hydroxylation of EGF-domain-containing proteins might
affect proteins that have been implicated in the pathogen-
esis of ectopia lentis, an interesting hypothesis that should
be tested by future studies.Supplemental Data
Supplemental Data include two figures and can be found with this
article online at http://dx.doi.org/10.1016/j.ajhg.2014.04.002.014
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